LWA
VIVO

Lenox Wealth Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Lenox Wealth Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-132
Closed -$1K – 831
2020
Q1 		$1K Hold
132
– – ﹤0.01% 746
2019
Q4 		$1K Hold
132
– – ﹤0.01% 708
2019
Q3 		$1K Buy
+132
New +$1.39K ﹤0.01% 607

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Lenox Wealth Advisors's VIVO Position: Q2 2020 in Review

Lenox Wealth Advisors sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 132 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in VIVO in Q3 2019 and held it in 3 quarters. The position peaked at $1K in Q1 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Lenox Wealth Advisors reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
  • Lenox Wealth Advisors sold 132 Meridian Bioscience Inc shares in Q2 2020, an estimated $1K.
  • Lenox Wealth Advisors first reported a position in Meridian Bioscience Inc in Q3 2019 and held it in 3 quarters.
  • Lenox Wealth Advisors's Meridian Bioscience Inc position peaked at $1K in Q1 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Lenox Wealth Advisors's 13F filing for Q2 2020, filed 14 Jul 2020.